BENZAZEPINE DICARBOXAMIDE COMPOUNDS

MA41625AUndetermined Publication Date: 2018-01-10F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MA41625
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2015-12-04
Filing Date
2016-03-03
Publication Date
2018-01-10
Patent Text Reader

Abstract

the present invention relates to novel benzazepine dicarboxamide compounds of formula (i) in which r 1 to r 4 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. Said compounds are tlr agonists and may therefore be useful as drugs for the treatment of diseases such as cancer, autoimmune diseases, inflammation, sepsis, allergy, asthma, transplant rejection, graft-versus-host disease, immunodeficiencies, and infectious diseases.<!--endfragment-->
Need to check novelty before this filing date? Find Prior Art